Med24
Medical Research 8. 10. 2026 • 2 min read • medical-news

Carterra advances lab-in-the-loop drug discovery through new scientific collaboration

Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery.

Carterra advances lab-in-the-loop drug discovery through new scientific collaboration

Carterra and AstraZeneca have initiated a research collaboration focused on advancing lab-in-the-loop drug discovery. This effort combines scientific and technical expertise to integrate laboratory systems, software, and data infrastructure with AI-driven discovery workflows. The collaboration addresses a growing industry interest in this model, which involves AI proposing drug candidates, followed by wet-lab experiments generating data for validation, and the data informing subsequent AI design. This approach is seen as a key shift in antibody discovery, as highlighted by recent reports from Leerink Partners and William Blair. The model emphasizes the need for consistent and comparable experimental data to effectively apply AI in drug discovery.

Sponsored content

At the core of this collaboration is the development of hardware and software designed to facilitate a connected, AI-enabled discovery loop. Carterra’s engineering and software teams are working with AstraZeneca’s scientists and automation experts to create laboratory systems capable of generating standardized data at scale. The resulting data will be directly usable in AI and machine learning workflows. This initiative responds to a recognized barrier in the field – the need for consistent experimental data across large-scale experiments.

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement